DEA, HHS extend telemedicine waivers through 2026 - aha.org
DEA and HHS have extended telemedicine waivers until 2026, allowing continued flexibility in prescribing controlled substances via telehealth.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on September 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. All telehealth platforms, virtual specialty clinics, and behavioral-health providers. should confirm how it applies to their specific situation before acting. There is a time constraint attached: 2026 (no specific date provided).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Telemedicine waivers for prescribing controlled substances have been extended through 2026.
Who it affects
All telehealth platforms, virtual specialty clinics, and behavioral-health providers.
What you must do
Continue operating under the existing telemedicine waivers without needing to apply for new licenses until 2026.
Deadline
2026 (no specific date provided).
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- Judge blocks Kansas law that banned prescribing abortion pills over telemedicine - kmuw.org
- Case asking who can dispense abortion-inducing drugs likely headed for Ohio Supreme Court - The Statehouse News Bureau
- Medicare Telehealth Flexibilities Extended Through 2027: Telehealth Gets a Two-Year Lifeline in Fiscal Year 2026 Spending Package - jdsupra.com
- Alaska Legislature formalizes rules for physician assistants working within the state - Alaska Beacon
- DEA, HHS delay implementation of buprenorphine final rule until Dec. 31 - aha.org